Chi-Med starts Phase I hematological malignancies study
The trial will enrol patients suffering from relapsed or refractory hematological malignancies. Credit: allinonemovie from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more